Hims' Roller Coaster Ride Continues With Surprise Losses, Light Sales And A Guidance Cut
Hims & Hers reported a surprise third-quarter loss and revenue below expectations, then cut its full-year outlook. The telehealth company cited climbing costs that are weighing on profitability. Shares extended losses in after-hours trading as investors digested the earnings stumble. The results mark a sharp reversal from prior quarters of steady growth and raise questions about the sustainability of its customer acquisition strategy.
Listen to Live Briefing
Real-time synthesized voice briefing Β· Live Feeds Desk
- β Hims & Hers reported third-quarter 2026 financial results.
- β The company posted a surprise loss for the quarter.
- β Revenue came in below analyst expectations.
- β Full-year guidance was lowered.
What changed
Hims & Hers posted a Q3 loss, missed sales estimates and reduced full-year guidance, triggering a sharp share-price decline.
Live updates
-
Hims & Hers shares sink after Q3 loss, sales miss and lowered guidance
Hims & Hers reported a surprise third-quarter loss and revenue below expectations, then cut its full-year outlook. The telehealth company cited climbing costs that are weighing on profitability. Shares extended losses in after-hours trading as investors digested the earnings stumble. The results mark a sharp reversal from prior quarters of steady growth and raise questions about the sustainability of its customer acquisition strategy.
Why it matters
The company had been a pandemic-era darling, expanding from hair-loss and sexual-health prescriptions into weight-loss and mental-health services. Recent quarters showed accelerating revenue but also rising marketing spend. The Q3 miss and guidance cut suggest that cost discipline is becoming a larger concern than top-line growth. Analysts are now focusing on whether the new weight-loss offerings can deliver margin improvement.
What is confirmed
- Hims & Hers reported third-quarter 2026 financial results.
- The company posted a surprise loss for the quarter.
- Revenue came in below analyst expectations.
- Full-year guidance was lowered.
- Climbing costs are weighing on the outlook.
- Shares extended losses after the earnings release.
Still unconfirmed
- Weight-loss offerings may not deliver margin improvement quickly enough.
- Customer acquisition costs are rising faster than anticipated.
What to watch next
- Management commentary on cost-control measures in the earnings call
- Q4 subscriber trends for weight-loss and mental-health segments
- Analyst revisions to 2027 revenue and margin estimates
confidence 88%Sources used for this update (5)
- HIMS investor relations β Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results
- WSJ β Hims & Hersβ Climbing Costs Weigh on Outlook
- Investor's Business Daily β Hims' Roller Coaster Ride Continues With Surprise Losses, Light Sales And A Guidance Cut
- Barron's β Hims & Hers Stock Extends Losses After Earnings Stumble
- Yahoo Finance β Hims & Hers stock sinks after Q3 results, outlook disappoints
Community Sentiment: How do you assess this situation?
Voice your perspective Β· Real-time aggregated sentiment from the Live Feeds community